Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 3,439 shares at $7.27 ($25K) on 2023-04-06, disclosed to the SEC on 2023-04-07.
Scheduled sale ($25k) by CFO and CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |